Why is "BRCA mutation" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-15 08:12:49
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
A BRCA mutation is a mutation in either of the BRCA1 and BRCA2 genes, which are tumour suppressor genes. Hundreds of different types of mutations in these genes have been identified, some of which have been determined to be harmful, while others have no proven impact. Harmful mutations in these genes may produce a hereditary breast–ovarian cancer syndrome in affected persons. Only 5–10% of breast cancer cases in women are attributed to BRCA1 and BRCA2 mutations, but the impact on women with the gene mutation is more profound. Women with harmful mutations in either BRCA1 or BRCA2 have a risk of breast cancer that is about five times the normal risk, and a risk of ovarian cancer that is about ten to thirty times normal. The risk of breast and ovarian cancer is higher for women with a high-risk BRCA1 mutation than with a BRCA2 mutation. Having a high-risk mutation does not guarantee that the woman will develop cancer, nor does it imply that any cancer that appears was caused by the mutation, rather than some other factor.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
FDA Grants Full Approval to Rucaparib for BRCA Mutation–Associated mCRPC - onclive.com
-
Breastfeeding After Breast Cancer: New Insights for BRCA Mutation Carriers - docwirenews.com
-
Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA Mutation - Beyond the Abstract - UroToday
-
Chemotherapy Regimens Compared in High-Grade Serous Ovarian Cancer With No BRCA Mutation - The ASCO Post
-
BRCA Mutations Up Risk of ALCL in Those with Textured Implants - Breast Cancer.org
-
Loay Kassem: Study Reveals BRCA Mutation Rates in Egyptian Women with Breast or Ovarian Cancer - Oncodaily
-
Nurse with BRCA mutation turns to IVF genetic testing to lessen cancer fears - CBS News
-
Early DNA breaks in BRCA carriers reveal the beginnings of breast cancer - EurekAlert!
-
Actress with BRCA Mutation Had a Double Mastectomy (Exclusive) - People.com
-
Managing elevated cancer risk in BRCA+ men - Penn Medicine
-
Biomarkers of psychological stress are associated with increased susceptibility to the development of breast and prostate cancer in BRCA1/2 mutation carriers | British Journal of Cancer - Nature
-
What to know after learning you have a BRCA mutation - UT MD Anderson
-
Inherited Cancer Risk: BRCA Mutation - Johns Hopkins Medicine
-
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation - The New England Journal of Medicine
-
The Angelina Jolie Effect: A Lasting Global Impact on Cancer Prevention - Oncodaily
-
Ashkenazi Dads Can Pass the BRCA Mutation to Their Kids. It Turns Out I Did. - Kveller
-
BRCA-mutation researcher Dr. Rosevalentine Bosire named Brave Fellow - Fred Hutchinson Cancer Center
-
A Long Island nurse knew she had an increased risk of cancer. Thanks to IVF genetic testing, her child won't have the same fear. - CBS News
-
Elisa Agostinetto: Risk-reducing surgeries improve survival of young patients with a BRCA mutation and breast cancer - Oncodaily
-
BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging ConsiderationsRadiology - RSNA Journals
-
Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan - Nature
-
PARP Inhibition Shows Efficacy in Ovarian Cancer Regardless of Number of Prior Lines of Chemotherapy, BRCA Mutation Status - The ASCO Post
-
Breastfeeding Cuts Ovarian Cancer Risk in BRCA Mutation Carriers - Cleveland Clinic
-
Kristy Hunter: ICD-10-CM Codes for BRCA Mutation - Oncodaily
-
Kerollos N. Wanis, MD, PhD, on Risks for BRCA Mutation Carriers Treated With Breast-Conserving Therapy - The ASCO Post
-
Large Study Verifies Cancer Risk for Women Carrying BRCA1 or BRCA2 Mutations - National Cancer Institute (.gov)
-
This Jewish teen is raising awareness about the cancer gene that killed his father - Jewish Telegraphic Agency
-
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation - The New England Journal of Medicine
-
Review Highlights the Need to Increase Germline BRCA Mutation Testing in Males - onclive.com
-
Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis - Wiley
-
Who Should Be Tested for the BRCA Mutation? - Cure Today
-
Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis - Nature
-
In Ovarian Cancer, Neoadjuvant Olaparib Feasible, Appears Effective in Pilot Study Among Patients With BRCA Mutation - The ASCO Post
-
BRCA Mutation in Ovarian Cancer: Implications for Screening, Diagnosis, and Preventive Measures - EMJ
-
BRCA Mutation Carriers With Early-Onset Breast Cancer May Benefit From Risk-Reducing Surgery - Cancer Health
-
Imaging-Based Prostate Cancer Screening Among BRCA Mutation Carriers - A UroToday Journal Club - UroToday
-
Overview on population screening for carriers with germline BRCA mutation in China - Frontiers
-
Free, Cheap, and Easy Ways to Get Tested for the BRCA Mutation - Kveller
-
Obesity as a promoter in BRCA mutation carriers - Nature
-
There’s an App for That: When the Meaning of a BRCA Mutation Isn’t Clear-Cut - Memorial Sloan Kettering Cancer Center
-
Undergoing genetic counseling and testing for a BRCA mutation - UT MD Anderson
-
Maintenance olaparib, compared with placebo, reduces the risk of disease progression in patients with advanced BRCA mutation ovarian cancer - 2minutemedicine.com
-
Carmine Valenza: The Role of Germline BRCA Mutation in PARP Inhibitors-Related Hematologic Adverse Events - Oncodaily
-
Aromatase Inhibitors May Decrease Risk of Contralateral Breast Cancer in BRCA Mutation–Positive Patients - The ASCO Post
-
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ - Nature
-
Testing for the BRCA mutation could save your life - health enews
-
Risk Stratification of BRCA Mutation Carriers May Help Guide Follow-up - The ASCO Post
-
Who Should Be Tested for a BRCA Mutation? The Science Is Evolving - Memorial Sloan Kettering Cancer Center
-
MDS, AML a Risk With PARP Inhibitors in BRCA Mutation Carriers - Hematology Advisor
-
BRCA Mutation: New Model Quantifies How Surgeries Reduce Cancer Risk - UCLA Anderson Review
-
Clinical Review Explores Role of Radiotherapy in BRCA Mutation Breast Cancer Treatment - Imaging Technology News
-
Obesity may increase risk for breast cancer among BRCA mutation carriers - healio.com
-
Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors - Frontiers
-
Risk-Reducing Mastectomy Questioned for BRCA Mutation Carriers with Prior Ovarian Cancer - Duke Health
-
News: FDA Clears 23andMe To Report 41 More BRCA Mutations - Breast Cancer.org
-
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution - Nature
-
The application of Raman spectroscopy and chemometric methods for analysis healthy blood and blood with BRCA mutation - medRxiv
-
Should All Breast Cancer Patients Get BRCA Testing? - Medscape
-
Surgical options for reducing risk in BRCA mutation carriers - Contemporary OB/GYN
-
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers - The New England Journal of Medicine
-
ASCO 2019: PARP Inhibitors Benefit People with Pancreatic Cancer Who Have a BRCA Mutation - Memorial Sloan Kettering Cancer Center
-
High BPE on breast MRI linked to BRCA mutation for breast cancer - AuntMinnie
-
Poor Outcomes of CDK4/6 Inhibitors in BRCA-Mutant Breast Cancer: What Mechanisms Might Be Responsible? - ASCO Daily News
-
Understanding the BRCA Gene and Your Risk for Prostate Cancer - Riverside Health
-
Raising Awareness of BRCA Mutations (Published 2018) - nytimes.com
-
Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations - Nature
-
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers - Frontiers
-
SOLO-1: practice-changing results for advanced ovarian cancer patients with BRCA mutation - Oncology Central
-
Large Retrospective Study Finds Pregnancy Safe Among Young BRCA Carriers - Cleveland Clinic
-
Women with BRCA mutation have better survival rates after double mastectomy - Wiley
-
Obesity May Exacerbate Breast Cancer Risk in Women with BRCA Mutations - WCM Newsroom
-
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer - The New England Journal of Medicine
-
Olaparib Approved for Treating Some Breast Cancers with BRCA Gene Mutations - National Cancer Institute (.gov)
-
I tested positive for the cancer-causing BRCA mutation. Now what? - Jewish Telegraphic Agency
-
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer - Nature
-
Olaparib for Pancreatic Cancer with BRCA Mutations - National Cancer Institute (.gov)
-
Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations - Nature
-
No higher risk of breast cancer for women who don't have BRCA mutation but have relatives who do - Stanford Medicine
-
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection - Frontiers
-
Serbian high-risk families: extensive results on BRCA mutation spectra and frequency - Nature
-
Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube - Nature
-
BRCA genetic testing and counseling in breast cancer: how do we meet our patients’ needs? | npj Breast Cancer - Nature
-
I Found Out My Grandma Had BRCA When I Was Diagnosed With Breast Cancer at 33 - Kveller
-
So you're BRCA, now what? - Fred Hutchinson Cancer Center
-
The role of genetics in breast and ovarian cancer - Sanford Health News
-
BRCA Testing: What You Need to Know - Dana-Farber Cancer Institute
-
Photo | BRCA mutation survival rate chart - Newsroom | UCLA
-
BRCA-mutant pancreatic ductal adenocarcinoma - Nature
-
In BRCA -Mutated Ovarian Cancer, Neoadjuvant Olaparib Feasible, Appears Effective in Pilot Study - The ASCO Post
-
Is BRCA-Positive Breast Cancer Treated Differently From BRCA-Negative? - Dana-Farber Cancer Institute
-
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers - Nature
-
BRCA mutation: After cancer prevention surgeries, women learn genetic test may have been wrong - CBS News
-
Long-Term PFS Benefit With Olaparib in nonBRCA-Mutant Ovarian Cancer More Likely With HRD Positivity - CancerNetwork
-
Oncologists, primary care clinicians should be aware of BRCA testing indications in men - healio.com
-
Were women foolish to follow Angelina Jolie into BRCA cancer gene testing? - statnews.com
-
Journalist with gene mutation decides to head off cancer by having breasts removed - WITF
-
All Ashkenazi Women Should Be Tested for BRCA - Kveller
-
BRCA mutations in men: Three things to know - Penn Medicine
-
Risk-benefits assessment of tamoxifen or raloxifene as chemoprevention for risk reduction of breast cancer among BRCA1 and BRCA2 carriers: a meta-analysis - Nature
-
Rucaparib Receives EC Approval for Advanced Ovarian Cancer - onclive.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.